FDA Import Refusal AEK-7564602-4/30002/1 — Incepta Pharmaceuticals Ltd
The FDA refused shipment AEK-7564602-4/30002/1 from Incepta Pharmaceuticals Ltd (Bangladesh) on Sep 23, 2025. The refused product falls under Drugs and Biologics — ESCITALOPRAM OXALATE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 23, 2025
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61NDY83 ESCITALOPRAM OXALATE
- Charges
- 75